Please confirm you are human (Sign Up for free to never see this)
← Back to Search
The Comparative Immunotoxicity Of Mesoporous Silica Nanoparticles And Colloidal Silica Nanoparticles In Mice
Soyoung Lee, M. Kim, D. Lee, T. Kwon, D. Khang, H. Yun, S. Kim
Published 2013 · Materials Science, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Background Mesoporous silica (MPS) nanoparticles (NPs), which have a unique pore structure and extremely large surface area and pore volume, have received much attention because of their biomedical application potential. Using MPS NPs for biomedical devices requires the verification of their biocompatibility because the surface area of NPs is one of the most important determinants of toxicity, including the cellular uptake and immune response. We have previously reported that the cytotoxicity and inflammation potential of MPS NPs have been shown to be lower than those of general amorphous colloidal silica (Col) NPs in macrophages, but the low cytotoxicity does not guarantee high biocompatibility in vivo. In this study, we compared the in vivo immunotoxicity of MPS and Col NPs in the mouse model to define the effects of pore structural conditions of silica NPs. Materials and methods Both MPS and Col NPs (2, 20, and 50 mg/kg/day) were intraperitoneally administered in female BALB/c mice for 4 weeks, and clinical toxicity, lymphocyte population, serum IgG/IgM levels, and histological changes were examined. Results There was no overt sign of clinical toxicity in either MPS- or Col-treated mice. However, MPS NPs led to significant increases in liver and spleen weight and splenocyte proliferation. Mice treated with MPS NPs showed altered lymphocyte populations (CD3+, CD45+, CD4+, and CD8+) in the spleen, increased serum IgG and IgM levels, and histological changes. Despite slight changes in lymphocyte populations in the spleen, Col NPs did not alter other immunological factors. Conclusion The results indicate that in vivo exposure to MPS NPs caused more damage to systemic immunity than that of Col NPs through the dysregulation of the spleen. The results for in vivo data are inconsistent with those for in vitro data, which show lower cytotoxicity for MPS NPs. These results suggest the importance of verifying biocompatibility both in vitro and in vivo during the design of new nanomaterials.
This paper references
PEGylation, successful approach to drug delivery.
F. Veronese (2005)
Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line.
Y. Ye (2010)
Design and preparation of bioactive glasses with hierarchical pore networks.
H. Yun (2007)
[Structure and function of immunoglobulins].
F. Seiler (1982)
Silica nanoparticles as hepatotoxicants.
H. Nishimori (2009)
Oral exposure to inorganic mercury alters T lymphocyte phenotypes and cytokine expression in BALB/c mice
S. Kim (2003)
Effect of the pore structure of bioactive glass balls on biocompatibility in vitro and in vivo.
H. Yun (2011)
Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
S. Roth (2008)
The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles.
Xuezi Sang (2012)
Making Hard Decisions
R. Clemen (2002)
Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice.
X. Lu (2011)
Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells.
D. Huang (2008)
Effect of Hydrophilic and Hydrophobic Nanoparticles on the Surface Pressure Response of DPPC Monolayers
E. Guzmán (2011)
Toxic effects of mercuric sulfide on immune organs in mice
Hee-young Son (2010)
Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen
K. Tan (2007)
Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Yannan Zhao (2011)
Hepatotoxicity of silica nanoparticles with a diameter of 100 nm.
T. Hasezaki (2011)
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
I. Slowing (2008)
Influence of silica nanoparticles on dilational rheology of DPPC–palmitic acid Langmuir monolayers
E. Guzmán (2012)
Non-viral gene transfer of murine spleen cells achieved by in vivo electroporation
E. Tupin (2003)
The biocompatibility of mesoporous silicates.
S. Hudson (2008)
Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles.
Tianlong Liu (2012)
Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.
R. Murdock (2008)
Nanomedicine and nanotoxicology: two sides of the same coin.
V. Kagan (2005)
Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells.
Erika Witasp (2009)
Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice.
Tianlong Liu (2011)
The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis.
S. Lee (2011)
Structure and function of the spleen
R. Mebius (2005)
Powered by TCPDF (www.tcpdf.org)
Histological analysis of 70-nm silica particles-induced chronic toxicity in mice.
H. Nishimori (2009)
Effect of 70-nm silica particles on the toxicity of acetaminophen, tetracycline, trazodone, and 5-aminosalicylic acid in mice.
X. Li (2011)
The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles.
Minjung Cho (2009)
In vitro toxicity of silica nanoparticles in human lung cancer cells.
W. Lin (2006)
Immunoglobulin responses to experimental silicosis.
S. H. Huang (2001)
Comparative immunotoxicity of silica NPs in vivo International Journal of Nanomedicine
Structure and function of immunoglobulins.
H. Schroeder (2010)
Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes
M. Bottini (2007)
Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice
Hee-young Son (2009)
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
G. Oberdörster (2010)
Paradoxical roles of the immune system during cancer development
K. E. D. Visser (2006)
Mesoporous silica particles induce size dependent effects on human dendritic cells.
H. Vallhov (2007)
Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro.
E. Park (2009)
Nanotoxicity: the growing need for in vivo study.
H. C. Fischer (2007)
Comparative immunotoxicity of silica NPs in vivo International Journal of Nanomedicine downloaded from
and nanotoxicology : two sides of the same coin
VE Kagan (2005)
Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles.
C. Sayes (2007)
Nanotoxicology and nanomedicine: making hard decisions.
I. Linkov (2008)
This paper is referenced by
The toxicity of silica nanoparticles to the immune system.
L. Chen (2018)
X. Li (2020)
Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.
R. K. Delong (2017)
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
Reema Narayan (2018)
Inducing Macrophages M2 Polarization by Dexamethasone Laden Mesoporous Silica Nanoparticles from Titanium Implant Surface for Enhanced Osteogenesis
J. Luo (2019)
Allergy and Immunotoxicology in Occupational Health - The Next Step
T. Otsuki (2020)
High drug-loading nanomedicines: progress, current status, and prospects
Shihong Shen (2017)
Carbon black nanoparticle exposure during middle and late fetal development induces immune activation in male offspring mice.
Y. El-Sayed (2015)
In vitro toxicological assessment of amorphous silica particles in relation to their characteristics and mode of action in human skin cells
Claudia Moia (2015)
Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge
J. Kim (2014)
Systemic Immune Effects of Titanium Dioxide Nanoparticles after Repeated Intratracheal Instillation in Rat
Y. Fu (2014)
Environmental Risks of Nanotechnology
M. Méndez-Rojas (2014)
Subchronic toxicity of silica nanoparticles as a function of size and porosity.
R. Mohammadpour (2019)
Impact of silica dioxide nanoparticles on the morphology of internal organs in rats by oral supplementation
N. Zaitseva (2016)
Global metabolomics approach in in vitro and in vivo models reveals hepatic glutathione depletion induced by amorphous silica nanoparticles.
Nivedita Chatterjee (2018)
Toxic Impacts of Amorphous Silica Nanoparticles on Liver and Kidney of Male Adult Rats: an In Vivo Study.
Rehab A Azouz (2020)
Template-based syntheses for shape controlled nanostructures.
M. Pérez-Page (2016)
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.
Alyssa B. Chinen (2015)
Nanomaterials in consumer's goods: the problems of risk assessment
I. V. Gmoshinski (2015)
The Toxicology of Silica Nanoparticles: A Review
P. Mohammadi (2018)
Silica Nanoparticles Effects on Blood Coagulation Proteins and Platelets
V. Gryshchuk (2016)
Understanding the mechanisms of silica nanoparticles for nanomedicine
Z. Li (2020)
Smart mesoporous silica nanoparticles for controlled-release drug delivery
Mahdi Karimi (2016)
Comparison of different cytotoxicity assays for in vitro evaluation of mesoporous silica nanoparticles.
Katharina Braun (2018)
Pulmonary toxicity of synthetic amorphous silica - effects of porosity and copper oxide doping.
Niels Hadrup (2020)
Efecto inmunomodulador de nanopartículas usadas en nanomedicina
Diana Maryory Gómez-Gallego (2016)
Mesoporous titania based yolk-shell nanoparticles as multifunctional theranostic platforms for SERS imaging and chemo-photothermal treatment.
W. Zhang (2014)
Co-disposition of chitosan nanoparticles by multi types of hepatic cells and their subsequent biological elimination: the mechanism and kinetic studies at the cellular and animal levels
Liqun Jiang (2019)
Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications
Jonas G. Croissant (2020)
Allergenicity and toxicology of inhaled silver nanoparticles in allergen-provocation mice models
Hsiao-Chi Chuang (2013)
Silica-based mesoporous nanoparticles for controlled drug delivery
Sooyeon Kwon (2013)
The application of mesoporous silica nanoparticle family in cancer theranostics
Yin Feng (2016)See more